Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05989880 · ClinicalTrials.gov registry record · NA
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
A NA study of Anesthesia, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05989880: Recruiting NA study of Anesthesia, sponsored by The University of Texas Health Science Center, Houston.
NCT05989880 is a NA study of Anesthesia that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05989880, a NA study of Anesthesia, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the feasibility of SafeLM as a primary airway device and as a conduit for intubation with and without the use of a bougie
Primary Outcome
This is assessed by the ability of the SafeLM to achieve adequate oxygenation and ventilation via the respective procedure once the airway device is in place.
Conditions Studied
Interventions
- DEVICE SafeLM as a supraglottic airway device with video capability
- DEVICE SafeLM as a supraglottic airway device without video capability
- DEVICE SafeLM as a conduit for intubation using an endotracheal tube with video capability
- DEVICE SafeLM as a conduit for intubation using a bougie with video capability
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2025-12-02 |
| Phase | NA |
What NCT05989880 shows while recruiting
NCT05989880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 4 interventions - of which SafeLM as a supraglottic airway device with video capability is the first listed.
NCT05989880 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05989880 about?
NCT05989880 is a clinical study titled "Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)". The purpose of this study is to assess the feasibility of SafeLM as a primary airway device and as a conduit for intubation with and without the use of a bougie
What is the current status of trial NCT05989880?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-09-19. Estimated completion is 2025-12-02.
What conditions does trial NCT05989880 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT05989880?
The interventions under investigation include: SafeLM as a supraglottic airway device with video capability (DEVICE), SafeLM as a supraglottic airway device without video capability (DEVICE), SafeLM as a conduit for intubation using an endotracheal tube with video capability (DEVICE), SafeLM as a conduit for intubation using a bougie with video capability (DEVICE).
Who is sponsoring clinical trial NCT05989880?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05989880 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05989880's enrollment target sits among peer trials
60 26th of 57 higher than 27 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
RECRUITING · NA
-
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
RECRUITING · NA
-
REcovery From DEXmedetomidine-induced Unconsciousness
RECRUITING · NA
-
Poke and a Placebo
RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI